Cargando…
Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
Aromatase inhibitors (AIs) are a key component in the chemoprevention and treatment of hormone receptor-positive (HR+) breast cancer. While the addition of AI therapy has improved cancer-related outcomes in the management of HR+ breast cancer, AIs are associated with musculoskeletal adverse effects...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353230/ https://www.ncbi.nlm.nih.gov/pubmed/34385978 http://dx.doi.org/10.3389/fendo.2021.713700 |